A Phase 2 Basket Study of Talabostat, a Small-Molecule Inhibitor of Dipeptidyl Peptidases, Administered in Combination with Pembrolizumab in Patients with Advanced Solid Cancers.

Jibran Ahmed,Filip Janku,Daniel D. Karp, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Timothy Anthony Yap,Bettzy Stephen, Yali Yang, Serdar Gurses, Qian Liu,Juhee Song,Funda Meric-Bernstam,Aung Naing

CANCER（2025）

Cited 0|Views0

Key words

cancer,immunotherapy,pembrolizumab,talabostat

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined